Calypso® Medical announces a strategic collaboration agreement with IMPAC Medical Systems at the American Society for Therapeutic Radiology and Oncology (ASTRO) 46th Annual Meeting

10.03.2004

Calypso® Medical Announces a Strategic Collaboration Agreement with IMPAC Medical Systems at the American Society for Therapeutic Radiology and Oncology (ASTRO) 46th Annual Meeting 

Atlanta, GA – October 3, 2004 – Calypso® Medical announces a strategic collaboration agreement IMPAC Medical Systems at the 46th Annual American Society for Therapeutic Radiology and Oncology (ASTRO) meeting, October 3 – 7. Calypso Medical intends to collaborate with IMPAC on future product offerings. 

The Calypso® 4D Localization System was designed to provide an objective and continuous method to setup treatment and monitor the patient during radiation delivery without adding ionizing radiation. “Working together with the leaders in the field of radiation therapy we can provide the ‘missing link’ to advance radiation treatment options. Today’s highly-conformal radiation therapy treatment options rely on knowing the exact location of the target moment to moment. Using our proprietary AC electromagnetic technology, the Calypso System provides an unparalleled capability to pinpoint the target continuously throughout the treatment process, without adding ionizing radiation. Our open-system architecture design enables the integration of localization and tracking information throughout the care pathway from simulation through treatment delivery. Establishing relationships with companies like IMPAC marks a commitment to advance planning and delivery techniques such as adaptive radiation therapy,” notes Eric R. Meier, Calypso Medical’s President and CEO. 

IMPAC intends to integrate target localization data generated from the Calypso® 4D Localization System into its electronic medical record (EMR) which currently streamlines treatment setup, verification, and recording on over 2400 linear accelerators worldwide. “Calypso Medical provides an innovative approach to patient localization. By introducing the technology to IMPAC’s large installed base along with new accelerator installations, the potential exists to accelerate the adoption of adaptive therapy,” said IMPAC’s President and CEO, Joseph K. Jachinowski. 

About IMPAC Medical Systems 

IMPAC Medical Systems, Inc. is a leading provider of oncology IT solutions that streamline both clinical and business operations to help improve the process of delivering quality patient care. With systems designed for anatomic pathology, medical oncology, radiation oncology, imaging, clinical laboratory, and cancer registry, IMPAC supports the entire team of healthcare professionals who contribute to the care of the cancer patient. Supporting more than 2500 installations worldwide, IMPAC provides practical solutions that deliver better overall communication, process efficiency and quality patient care. For more information about IMPAC Medical Systems, please call 888-GO-IMPAC or visit www.impac.com.

Lynn Purdy
Senior Director Marketing
Calypso® Medical
(206) 254-0600
lpurdy@calypsomedical.com